Sebastian Bauer

37PUBLICATIONS
267CO-AUTHORS
Evolutionary ecologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Jun 11, 2026
Predicting Clinical Sensitivities of PDGFRA Exon 18 Mutations to Imatinib and Avapritinib to Optimize Gastrointestinal Stromal Tumor Treatment.

|Apr 09, 2026
Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumor.

Marcus Renner, Małgorzata Oleś, Nagarajan Paramasivam

|Jul 29, 2025
Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial).

Johanna Falkenhorst, Philipp Ivanyi, Tom Schulz

|Jul 04, 2025
Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN study.

Andrew J Wagner, William D Tap, Sebastian Bauer

|May 23, 2025
Updated Overall Survival and Long-Term Safety With Ripretinib Versus Sunitinib in Patients With GI Stromal Tumor: Final Overall Survival Analysis From INTRIGUE.

Michael C Heinrich, Jean-Yves Blay, Hans Gelderblom

|Jan 30, 2025
Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligence.

Julius Keyl, Philipp Keyl, Grégoire Montavon

Pageof 7

Frequent Collaborators

11 joint publications

Michael C Heinrich

9 joint publications

Hans Gelderblom

8 joint publications

Jean-Yves Blay

8 joint publications

Robin L Jones